Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

Key Findings

• ●5-year safety data
• ●Safe and well-tolerated
• ●Injection site reactions manageable

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 01:59 PMby pubmed-api

   PMID/DOI resolved and recorded from PubMed E-utilities during SEO DOI backfill.

   tools: pubmed.esummary